{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T11:48:16Z","timestamp":1786794496329,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,1,22]],"date-time":"2010-01-22T00:00:00Z","timestamp":1264118400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00415-010-5455-1","type":"journal-article","created":{"date-parts":[[2010,1,21]],"date-time":"2010-01-21T14:51:17Z","timestamp":1264085477000},"page":"1021-1026","source":"Crossref","is-referenced-by-count":17,"title":["Serum uric acid levels and neuromyelitis optica"],"prefix":"10.1007","volume":"257","author":[{"given":"Fuhua","family":"Peng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiufeng","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhui","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youming","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqiang","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,1,22]]},"reference":[{"key":"5455_CR1","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1073\/pnas.94.6.2528","volume":"94","author":"DC Hooper","year":"1997","unstructured":"Hooper DC, Bagasra O, Marini JC, Zborek A, Ohnishi ST, Kean R, Champion JM, Sarker AB, Bobroski L, Farber JL, Akaike T, Maeda H, Koprowski H (1997) Prevention of experimental allergic encephalo-myelitis by targeting nitric oxide and peroxynitrite: implications for the treatment of multiple sclerosis. Proc Natl Acad Sci USA 94:2528\u20132533","journal-title":"Proc Natl Acad Sci USA"},{"key":"5455_CR2","doi-asserted-by":"crossref","first-page":"6858","DOI":"10.1073\/pnas.78.11.6858","volume":"78","author":"BN Ames","year":"1981","unstructured":"Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 78:6858\u20136862","journal-title":"Proc Natl Acad Sci USA"},{"key":"5455_CR3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1096\/fasebj.14.5.691","volume":"14","author":"DC Hooper","year":"2000","unstructured":"Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV (2000) Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J 14:691\u2013698","journal-title":"FASEB J"},{"key":"5455_CR4","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1073\/pnas.95.2.675","volume":"95","author":"DC Hooper","year":"1998","unstructured":"Hooper DC, Spitsin S, Kean RB, Champion JM, Dickson GM, Chaudhry I, Koprowski H (1998) Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalo-myelitis and multiple sclerosis. Proc Natl Acad Sci USA 95:675\u2013680","journal-title":"Proc Natl Acad Sci USA"},{"key":"5455_CR5","doi-asserted-by":"crossref","first-page":"16303","DOI":"10.1073\/pnas.212645999","volume":"99","author":"GS Scott","year":"2002","unstructured":"Scott GS, Spitsin SV, Kean RB, Mikheeva T, Koprowski H, Hooper DC (2002) Therapeutic intervention in experimental allergic encephalomyelitis by administration of uric acid precursors. Proc Natl Acad Sci USA 99:16303\u201316308","journal-title":"Proc Natl Acad Sci USA"},{"key":"5455_CR6","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1212\/WNL.53.5.1107","volume":"53","author":"DM Wingerchuk","year":"1999","unstructured":"Wingerchuk DM, Hogancamp WF, O\u2019Brien PC, Weinshenker BG (1999) The clinical course of neuromyelitis optica (Devic\u2019s syndrome). Neurology 53:1107\u20132214","journal-title":"Neurology"},{"issue":"4","key":"5455_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0404.2008.01002.x","volume":"118","author":"AA Argyriou","year":"2008","unstructured":"Argyriou AA, Makris N (2008) Neuromyelitis optica: a distinct demyelinating disease of the central nervous system. Acta Neurol Scand 118(4):209\u2013217","journal-title":"Acta Neurol Scand"},{"key":"5455_CR8","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-1331.2002.00384.x","volume":"9","author":"G Toncev","year":"2002","unstructured":"Toncev G, Milicic B, Toncev S, Samardzic G (2002) Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood\u2013brain barrier dysfunction. Eur J Neurol 9:221\u2013226","journal-title":"Eur J Neurol"},{"key":"5455_CR9","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.clineuro.2005.08.004","volume":"108","author":"M Rentzos","year":"2006","unstructured":"Rentzos M, Nikolaou C, Anagnostouli M, Rombos A, Tsakanikas K, Economou M, Dimitrakopoulos A, Karouli M, Vassilopoulos D (2006) Serum uric acid and multiple sclerosis. Clin Neurol Neurosurg 108:527\u2013531","journal-title":"Clin Neurol Neurosurg"},{"key":"5455_CR10","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1191\/1352458504ms1042oa","volume":"10","author":"CM Knapp","year":"2004","unstructured":"Knapp CM, Constantinescu CS, Tan JH, McLean R, Cherryman GR, Gottlob I (2004) Serum uric acid levels in optic neuritis. Mult Scler 10:278\u2013280","journal-title":"Mult Scler"},{"issue":"2","key":"5455_CR11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1177\/1352458507082143","volume":"14","author":"F Peng","year":"2008","unstructured":"Peng F, Zhang B, Zhong X, Li J, Xu G, Hu X, Qiu W, Pei Z (2008) Serum uric acid levels of patients with multiple sclerosis and other neurological diseases. Mult Scler 14(2):188\u2013196","journal-title":"Mult Scler"},{"key":"5455_CR12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.clineuro.2004.02.008","volume":"106","author":"A Miller","year":"2004","unstructured":"Miller A, Glass-Marmor L, Abraham M, Grossman I, Shapiro S, Galboiz Y (2004) Bio-markers of disease activity and response to therapy in multiple sclerosis. Clin Neurol Neurosurg 106:249\u2013254","journal-title":"Clin Neurol Neurosurg"},{"key":"5455_CR13","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"5455_CR14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485\u20131489","journal-title":"Neurology"},{"key":"5455_CR15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227\u2013231","journal-title":"Ann Neurol"},{"key":"5455_CR16","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O\u2019Connor PW, Sandberg-Wollheim M, Thompson AJ, Weinshenker BG, Wolinsky JS (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the \u201cMcDonald Criteria\u201d. Ann Neurol 58:840\u2013846","journal-title":"Ann Neurol"},{"issue":"1","key":"5455_CR17","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ncl.2004.09.002","volume":"23","author":"CF Lucchinetti","year":"2005","unstructured":"Lucchinetti CF, Parisi J, Bruck W (2005) The pathology of multiple sclerosis. Neurol Clin 23(1):77\u2013105","journal-title":"Neurol Clin"},{"key":"5455_CR18","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jns.2005.03.012","volume":"233","author":"V Calabrese","year":"2005","unstructured":"Calabrese V, Lodi R, Tonon C (2005) Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich\u2019s ataxia. J Neurol Sci 233:145\u2013162","journal-title":"J Neurol Sci"},{"key":"5455_CR19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1476-9255-6-18","volume":"6","author":"G Pent\u00f3n-Rol","year":"2009","unstructured":"Pent\u00f3n-Rol G, Cervantes-Llanos M, Mart\u00ednez-S\u00e1nchez G, Cabrera-G\u00f3mez JA, Valenzuela-Silva CM, Ram\u00edrez-Nu\u00f1ez O, Casanova-Orta M, Robinson-Agramonte MA, Lopategui-Cabezas I, L\u00f3pez-Saura PA (2009) TNF-alpha and IL-10 downregulation and marked oxidative stress in Neuromyelitis Optica. J Inflamm (Lond) 6:18","journal-title":"J Inflamm (Lond)"},{"key":"5455_CR20","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2174\/092986705774462833","volume":"12","author":"JR Kanwar","year":"2005","unstructured":"Kanwar JR (2005) Anti-inflammatory immunotherapy for multiple sclerosis\/experimental autoimmune encephalomyelitis (EAE) disease. Curr Med Chem 12:2947\u20132962","journal-title":"Curr Med Chem"},{"key":"5455_CR21","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1073\/pnas.0500307102","volume":"102","author":"GS Scott","year":"2005","unstructured":"Scott GS, Cuzzocrea S, Genovese T, Koprowski H, Hooper DC (2005) Uric acid protects against secondary damage after spinal cord injury. Proc Natl Acad Sci USA 102:3483\u20133488","journal-title":"Proc Natl Acad Sci USA"},{"key":"5455_CR22","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1086\/315048","volume":"180","author":"S Kastenbauer","year":"1999","unstructured":"Kastenbauer S, Koedel U, Pfister HW (1999) Role of peroxynitrite as a mediator of pathophysiological alterations in experimental pneumococcal meningitis. J Infect Dis 180:1164\u20131170","journal-title":"J Infect Dis"},{"issue":"2","key":"5455_CR23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s004150170246","volume":"248","author":"J Drulovi\u0107","year":"2001","unstructured":"Drulovi\u0107 J, Dujmovi\u0107 I, Stojsavljevi\u0107 N, Mesaros S, Andjelkovi\u0107 S, Miljkovi\u0107 D, Peri\u0107 V, Dragutinovi\u0107 G, Marinkovi\u0107 J, Levi\u0107 Z, Mostarica Stojkovi\u0107 M (2001) Uric acid levels in sera from patients with multiple sclerosis. J Neurol 248(2):121\u2013126","journal-title":"J Neurol"},{"key":"5455_CR24","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/1531-8249(200101)49:1<139::AID-ANA28>3.0.CO;2-A","volume":"49","author":"H Koprowski","year":"2001","unstructured":"Koprowski H, Spitsin SV, Hooper DC (2001) Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann Neurol 49:139","journal-title":"Ann Neurol"},{"key":"5455_CR25","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1001\/jama.283.18.2404","volume":"283","author":"J Fang","year":"2000","unstructured":"Fang J, Alderman MH (2000) Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971\u20131992: National Health and Nutrition Examination Survey. JAMA 283:2404\u20132410","journal-title":"JAMA"},{"key":"5455_CR26","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s100720200059","volume":"23","author":"S Sotgiu","year":"2002","unstructured":"Sotgiu S, Pugliatti M, Sanna A, Sotgiu A, Fois ML, Arru G, Rosati G (2002) Serum uric acid and multiple sclerosis. Neurol Sci 23:183\u2013188","journal-title":"Neurol Sci"},{"key":"5455_CR27","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11940-005-0010-6","volume":"7","author":"DM Wingerchuk","year":"2005","unstructured":"Wingerchuk DM, Weinshenker BG (2005) Neuromyelitis Optica. Curr Treat Options Neurol 7:173\u2013182","journal-title":"Curr Treat Options Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5455-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-010-5455-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-010-5455-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T15:12:56Z","timestamp":1559056376000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-010-5455-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1,22]]},"references-count":27,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["5455"],"URL":"https:\/\/doi.org\/10.1007\/s00415-010-5455-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,1,22]]}}}